
Verona Pharma’s Breakout Stood Out in a Weak Market
Patrick Dunuwila and Alfonso DePablos favored Verona’s relative strength on September 10, 2024, while separating bullish momentum from warning signs in Pennant, Check Point and Twist.
IDEAS / Tickers
Check Point Software Technologies

Patrick Dunuwila and Alfonso DePablos favored Verona’s relative strength on September 10, 2024, while separating bullish momentum from warning signs in Pennant, Check Point and Twist.